HAP Trading, LLC - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 169 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2021. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
HAP Trading, LLC ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q4 2021$174,000
-73.6%
14,100
-66.6%
0.01%
-77.3%
Q3 2021$660,000
+1550.0%
42,260
+185.5%
0.02%
+2100.0%
Q2 2021$40,000
-59.2%
14,800
-86.3%
0.00%
-66.7%
Q4 2020$98,000
-76.6%
108,300
-11.4%
0.00%
-85.7%
Q3 2020$418,000
-83.0%
122,300
-87.5%
0.02%
-84.4%
Q2 2020$2,457,000
+7578.1%
981,427
+7508.0%
0.14%
+6650.0%
Q1 2020$32,000
-99.7%
12,900
-99.6%
0.00%
-99.7%
Q4 2019$12,193,000
+1561.2%
3,196,600
+84.7%
0.67%
+1032.2%
Q3 2019$734,000
+280.3%
1,731,100
+746.1%
0.06%
+293.3%
Q2 2019$193,000204,600
+888.4%
0.02%
Q4 2018$0
-100.0%
20,700
-68.4%
0.00%
-100.0%
Q3 2017$338,000
+11166.7%
65,566
+111.5%
0.02%
Q2 2017$3,000
-94.2%
31,000
-2.8%
0.00%
-100.0%
Q1 2017$52,000
-77.4%
31,900
-35.9%
0.00%
-62.5%
Q3 2016$230,00049,8000.01%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders